| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrometry, Mass, Electrospray Ionization | 52 | 2022 | 91 | 14.290 |
Why?
|
| Mass Spectrometry | 45 | 2024 | 290 | 8.860 |
Why?
|
| Transferrin | 27 | 2019 | 67 | 6.800 |
Why?
|
| Proteins | 27 | 2022 | 742 | 6.320 |
Why?
|
| Protein Conformation | 38 | 2021 | 771 | 4.730 |
Why?
|
| Heparin | 11 | 2024 | 111 | 4.580 |
Why?
|
| Deuterium Exchange Measurement | 12 | 2019 | 18 | 3.250 |
Why?
|
| Immunoglobulin G | 7 | 2022 | 452 | 3.100 |
Why?
|
| Hydrogen | 13 | 2014 | 50 | 2.670 |
Why?
|
| Biological Products | 5 | 2022 | 95 | 2.380 |
Why?
|
| Thrombocytopenia | 3 | 2024 | 49 | 2.380 |
Why?
|
| Immunoglobulin E | 5 | 2022 | 85 | 2.210 |
Why?
|
| Disulfides | 5 | 2024 | 62 | 2.140 |
Why?
|
| Iron | 13 | 2015 | 144 | 1.970 |
Why?
|
| Haptoglobins | 4 | 2022 | 15 | 1.940 |
Why?
|
| Hemoglobins | 5 | 2021 | 138 | 1.930 |
Why?
|
| Models, Molecular | 23 | 2019 | 1129 | 1.890 |
Why?
|
| Platelet Factor 4 | 3 | 2024 | 11 | 1.830 |
Why?
|
| Chromatography, Gel | 9 | 2022 | 65 | 1.690 |
Why?
|
| Spike Glycoprotein, Coronavirus | 3 | 2022 | 94 | 1.640 |
Why?
|
| Protein Binding | 21 | 2021 | 1559 | 1.500 |
Why?
|
| Receptors, Retinoic Acid | 8 | 2012 | 55 | 1.450 |
Why?
|
| Antithrombins | 3 | 2020 | 16 | 1.440 |
Why?
|
| Glycosaminoglycans | 3 | 2018 | 18 | 1.410 |
Why?
|
| Chromatography, Ion Exchange | 4 | 2018 | 23 | 1.390 |
Why?
|
| Recombinant Proteins | 15 | 2020 | 695 | 1.310 |
Why?
|
| Antithrombin III | 4 | 2016 | 14 | 1.270 |
Why?
|
| Fibroblast Growth Factor 1 | 2 | 2020 | 2 | 1.260 |
Why?
|
| Tandem Mass Spectrometry | 5 | 2017 | 135 | 1.210 |
Why?
|
| Amino Acid Sequence | 21 | 2024 | 1579 | 1.200 |
Why?
|
| Hydrogen-Ion Concentration | 18 | 2019 | 427 | 1.170 |
Why?
|
| Ions | 10 | 2021 | 52 | 1.120 |
Why?
|
| Glucosylceramidase | 3 | 2012 | 39 | 1.120 |
Why?
|
| Oxidation-Reduction | 3 | 2024 | 305 | 1.060 |
Why?
|
| Glycosylation | 10 | 2022 | 134 | 1.030 |
Why?
|
| Muramidase | 3 | 2015 | 47 | 1.030 |
Why?
|
| Chromatography, High Pressure Liquid | 7 | 2015 | 197 | 1.000 |
Why?
|
| Antibodies, Monoclonal | 5 | 2024 | 857 | 1.000 |
Why?
|
| Deuterium | 6 | 2014 | 23 | 0.990 |
Why?
|
| Humans | 60 | 2024 | 59799 | 0.960 |
Why?
|
| Molecular Sequence Data | 19 | 2016 | 1976 | 0.910 |
Why?
|
| Iodoacetic Acid | 2 | 2015 | 2 | 0.890 |
Why?
|
| Protein Structure, Secondary | 9 | 2018 | 253 | 0.830 |
Why?
|
| Myoglobin | 4 | 2016 | 27 | 0.820 |
Why?
|
| Biopolymers | 2 | 2014 | 70 | 0.790 |
Why?
|
| Interferon-beta | 2 | 2015 | 76 | 0.790 |
Why?
|
| Drug Delivery Systems | 3 | 2016 | 310 | 0.750 |
Why?
|
| Vaccines | 1 | 2022 | 97 | 0.750 |
Why?
|
| Ligands | 9 | 2018 | 421 | 0.740 |
Why?
|
| Ovalbumin | 1 | 2021 | 113 | 0.740 |
Why?
|
| Receptors, Virus | 1 | 2021 | 82 | 0.740 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 68 | 0.730 |
Why?
|
| Oxygen Isotopes | 4 | 2015 | 9 | 0.730 |
Why?
|
| Animals | 32 | 2022 | 19718 | 0.720 |
Why?
|
| Polysaccharide-Lyases | 1 | 2020 | 3 | 0.700 |
Why?
|
| Lactoglobulins | 2 | 2018 | 51 | 0.700 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 39 | 0.700 |
Why?
|
| Oligosaccharides | 1 | 2020 | 63 | 0.680 |
Why?
|
| Protein Folding | 7 | 2007 | 258 | 0.670 |
Why?
|
| Gallium | 2 | 2016 | 12 | 0.670 |
Why?
|
| Ruthenium | 1 | 2019 | 4 | 0.650 |
Why?
|
| Gases | 5 | 2020 | 20 | 0.650 |
Why?
|
| Interferon beta-1a | 2 | 2017 | 9 | 0.640 |
Why?
|
| Indicators and Reagents | 2 | 2016 | 43 | 0.620 |
Why?
|
| Receptors, Transferrin | 4 | 2013 | 35 | 0.620 |
Why?
|
| Factor Xa | 1 | 2018 | 6 | 0.620 |
Why?
|
| Lactalbumin | 1 | 2018 | 6 | 0.610 |
Why?
|
| Binding Sites | 9 | 2020 | 870 | 0.610 |
Why?
|
| Solutions | 8 | 2020 | 62 | 0.610 |
Why?
|
| Ubiquitin | 6 | 2013 | 95 | 0.590 |
Why?
|
| Nucleosides | 1 | 2017 | 11 | 0.580 |
Why?
|
| Isotope Labeling | 3 | 2012 | 68 | 0.570 |
Why?
|
| Organophosphonates | 1 | 2017 | 21 | 0.570 |
Why?
|
| Indium | 2 | 2015 | 7 | 0.570 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 187 | 0.570 |
Why?
|
| Hot Temperature | 1 | 2018 | 127 | 0.570 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 199 | 0.560 |
Why?
|
| Cysteine | 2 | 2015 | 109 | 0.560 |
Why?
|
| Polysaccharides | 1 | 2018 | 146 | 0.530 |
Why?
|
| Temperature | 5 | 2022 | 298 | 0.530 |
Why?
|
| Asparagine | 2 | 2013 | 24 | 0.530 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 163 | 0.500 |
Why?
|
| Cystine | 1 | 2015 | 2 | 0.490 |
Why?
|
| Reducing Agents | 1 | 2015 | 2 | 0.490 |
Why?
|
| Molecular Imaging | 1 | 2015 | 47 | 0.480 |
Why?
|
| Specimen Handling | 1 | 2015 | 56 | 0.460 |
Why?
|
| Peptides | 7 | 2019 | 545 | 0.460 |
Why?
|
| Macromolecular Substances | 2 | 2018 | 160 | 0.440 |
Why?
|
| Cattle | 6 | 2018 | 306 | 0.440 |
Why?
|
| Electrons | 1 | 2013 | 34 | 0.440 |
Why?
|
| Acids | 2 | 2011 | 14 | 0.440 |
Why?
|
| alpha-Synuclein | 2 | 2012 | 22 | 0.430 |
Why?
|
| Polymers | 1 | 2017 | 317 | 0.430 |
Why?
|
| Aspartic Acid | 1 | 2013 | 29 | 0.430 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2013 | 3 | 0.420 |
Why?
|
| Kinetics | 11 | 2013 | 737 | 0.420 |
Why?
|
| Static Electricity | 3 | 2022 | 165 | 0.400 |
Why?
|
| Dimerization | 5 | 2021 | 146 | 0.390 |
Why?
|
| Protein Stability | 3 | 2018 | 83 | 0.390 |
Why?
|
| Protein Denaturation | 5 | 2018 | 66 | 0.380 |
Why?
|
| Protein Structure, Tertiary | 4 | 2018 | 664 | 0.380 |
Why?
|
| Chromatography, Liquid | 4 | 2017 | 120 | 0.370 |
Why?
|
| Biotechnology | 1 | 2011 | 42 | 0.370 |
Why?
|
| Allergens | 3 | 2021 | 45 | 0.370 |
Why?
|
| Metalloproteins | 2 | 2011 | 13 | 0.370 |
Why?
|
| Drug Carriers | 1 | 2013 | 175 | 0.360 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 439 | 0.350 |
Why?
|
| Virus Internalization | 2 | 2022 | 99 | 0.350 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 121 | 0.330 |
Why?
|
| Milk | 3 | 2018 | 51 | 0.330 |
Why?
|
| Peptide Mapping | 3 | 2012 | 29 | 0.320 |
Why?
|
| Lipid A | 5 | 2008 | 70 | 0.320 |
Why?
|
| Chickens | 2 | 2021 | 91 | 0.310 |
Why?
|
| Endosomes | 1 | 2009 | 169 | 0.290 |
Why?
|
| Feasibility Studies | 3 | 2015 | 523 | 0.290 |
Why?
|
| Tretinoin | 1 | 2007 | 48 | 0.290 |
Why?
|
| Hemoglobin H | 1 | 2007 | 1 | 0.280 |
Why?
|
| Protein Unfolding | 2 | 2020 | 13 | 0.270 |
Why?
|
| Peptide Fragments | 3 | 2012 | 353 | 0.260 |
Why?
|
| Nickel | 2 | 2017 | 65 | 0.260 |
Why?
|
| Solvents | 3 | 2021 | 58 | 0.250 |
Why?
|
| Carbonates | 2 | 2015 | 3 | 0.240 |
Why?
|
| Oxalates | 2 | 2015 | 17 | 0.240 |
Why?
|
| Alkylation | 3 | 2015 | 11 | 0.240 |
Why?
|
| Protons | 1 | 2004 | 61 | 0.230 |
Why?
|
| Hydrolysis | 4 | 2012 | 139 | 0.230 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2024 | 9 | 0.230 |
Why?
|
| Pharmaceutical Preparations | 2 | 2017 | 122 | 0.230 |
Why?
|
| Antigen-Antibody Complex | 1 | 2024 | 49 | 0.230 |
Why?
|
| Heme | 1 | 2003 | 27 | 0.220 |
Why?
|
| Protein Subunits | 1 | 2024 | 165 | 0.220 |
Why?
|
| Autoantibodies | 1 | 2024 | 175 | 0.210 |
Why?
|
| Immunologic Factors | 1 | 2024 | 99 | 0.210 |
Why?
|
| Apoproteins | 4 | 2007 | 18 | 0.210 |
Why?
|
| Blood Platelets | 1 | 2024 | 101 | 0.210 |
Why?
|
| Protein Multimerization | 2 | 2017 | 167 | 0.210 |
Why?
|
| Proteomics | 1 | 2005 | 261 | 0.210 |
Why?
|
| Multiprotein Complexes | 1 | 2024 | 152 | 0.210 |
Why?
|
| Tetanus | 1 | 2022 | 5 | 0.210 |
Why?
|
| Algorithms | 4 | 2015 | 995 | 0.210 |
Why?
|
| Tetanus Toxin | 1 | 2022 | 8 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 255 | 0.200 |
Why?
|
| Vanadates | 1 | 2022 | 7 | 0.200 |
Why?
|
| Crystallography, X-Ray | 3 | 2016 | 422 | 0.200 |
Why?
|
| Protein Interaction Mapping | 2 | 2013 | 72 | 0.200 |
Why?
|
| Autistic Disorder | 2 | 2015 | 169 | 0.200 |
Why?
|
| Protein Aggregates | 1 | 2022 | 18 | 0.190 |
Why?
|
| Carbohydrate Sequence | 3 | 2020 | 22 | 0.190 |
Why?
|
| Cricetinae | 4 | 2018 | 376 | 0.190 |
Why?
|
| Egg Hypersensitivity | 1 | 2021 | 2 | 0.190 |
Why?
|
| Models, Chemical | 3 | 2008 | 135 | 0.180 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 1997 | 82 | 0.180 |
Why?
|
| Pepsin A | 2 | 2012 | 6 | 0.180 |
Why?
|
| Spectrum Analysis | 3 | 2017 | 51 | 0.180 |
Why?
|
| Bacteroides | 1 | 2020 | 9 | 0.180 |
Why?
|
| Ion Mobility Spectrometry | 1 | 2020 | 2 | 0.180 |
Why?
|
| Mutation | 2 | 2007 | 2461 | 0.170 |
Why?
|
| Nicotine | 1 | 2021 | 111 | 0.170 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 31 | 0.170 |
Why?
|
| Protein Domains | 1 | 2020 | 140 | 0.170 |
Why?
|
| Multivariate Analysis | 1 | 2022 | 925 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2022 | 314 | 0.160 |
Why?
|
| Metabolome | 1 | 2019 | 24 | 0.160 |
Why?
|
| Escherichia coli | 5 | 2022 | 688 | 0.160 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2013 | 293 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 160 | 0.150 |
Why?
|
| Ultrasonics | 1 | 2018 | 16 | 0.150 |
Why?
|
| Carbonic Anhydrases | 2 | 2008 | 8 | 0.150 |
Why?
|
| Circular Dichroism | 3 | 2012 | 107 | 0.150 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 33 | 0.150 |
Why?
|
| Biochemical Phenomena | 1 | 2018 | 2 | 0.150 |
Why?
|
| Blood Coagulation | 1 | 2018 | 39 | 0.150 |
Why?
|
| Cyclotrons | 2 | 2018 | 3 | 0.150 |
Why?
|
| Biophysical Phenomena | 1 | 2018 | 21 | 0.150 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 83 | 0.150 |
Why?
|
| Cobalt | 1 | 2017 | 16 | 0.150 |
Why?
|
| Ultrasonic Waves | 1 | 2017 | 4 | 0.150 |
Why?
|
| Cricetulus | 1 | 2018 | 102 | 0.150 |
Why?
|
| Tenofovir | 1 | 2017 | 8 | 0.140 |
Why?
|
| CHO Cells | 1 | 2018 | 190 | 0.140 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 252 | 0.140 |
Why?
|
| Cytosine | 1 | 2017 | 30 | 0.140 |
Why?
|
| Melitten | 1 | 1997 | 2 | 0.140 |
Why?
|
| Adenine | 1 | 2017 | 46 | 0.140 |
Why?
|
| Polyelectrolytes | 1 | 2017 | 7 | 0.140 |
Why?
|
| HIV | 1 | 2017 | 69 | 0.140 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 260 | 0.130 |
Why?
|
| Serum Albumin | 1 | 2015 | 38 | 0.130 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 460 | 0.130 |
Why?
|
| Limit of Detection | 1 | 2015 | 41 | 0.130 |
Why?
|
| Nanomedicine | 1 | 2015 | 24 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2017 | 194 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2017 | 336 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 623 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 751 | 0.120 |
Why?
|
| Metallothionein | 1 | 1995 | 8 | 0.120 |
Why?
|
| Alkylating Agents | 1 | 1995 | 9 | 0.120 |
Why?
|
| Dithiothreitol | 1 | 2015 | 18 | 0.120 |
Why?
|
| Melphalan | 1 | 1995 | 22 | 0.120 |
Why?
|
| Isomerism | 2 | 2013 | 27 | 0.120 |
Why?
|
| Rats, Wistar | 1 | 2015 | 179 | 0.120 |
Why?
|
| Swine | 1 | 2016 | 349 | 0.120 |
Why?
|
| Escherichia coli Proteins | 1 | 2017 | 261 | 0.120 |
Why?
|
| Calibration | 1 | 2015 | 64 | 0.120 |
Why?
|
| Molecular Structure | 3 | 2013 | 377 | 0.120 |
Why?
|
| Mice | 5 | 2022 | 10303 | 0.120 |
Why?
|
| Chromatography | 2 | 2012 | 16 | 0.110 |
Why?
|
| Reference Values | 1 | 2015 | 321 | 0.110 |
Why?
|
| Rats | 3 | 2015 | 1918 | 0.110 |
Why?
|
| Fourier Analysis | 1 | 2013 | 32 | 0.110 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2013 | 21 | 0.110 |
Why?
|
| Plant Proteins | 2 | 2005 | 82 | 0.110 |
Why?
|
| Micrococcus | 1 | 2013 | 3 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 63 | 0.110 |
Why?
|
| Central Nervous System Agents | 1 | 2013 | 6 | 0.110 |
Why?
|
| Polylysine | 1 | 2013 | 49 | 0.110 |
Why?
|
| Electrolytes | 1 | 2013 | 24 | 0.110 |
Why?
|
| Amides | 2 | 2004 | 51 | 0.110 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 52 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 34 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 81 | 0.100 |
Why?
|
| Horses | 2 | 2003 | 49 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2012 | 358 | 0.100 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 71 | 0.100 |
Why?
|
| Catalysis | 2 | 2011 | 154 | 0.100 |
Why?
|
| Biological Transport | 1 | 2013 | 288 | 0.100 |
Why?
|
| Ultracentrifugation | 1 | 2012 | 28 | 0.100 |
Why?
|
| Histidine | 2 | 2002 | 31 | 0.100 |
Why?
|
| Oryza | 1 | 2012 | 34 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 1097 | 0.100 |
Why?
|
| Deamination | 1 | 2011 | 9 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2012 | 195 | 0.090 |
Why?
|
| Light | 1 | 2012 | 201 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 144 | 0.090 |
Why?
|
| Proteolysis | 1 | 2012 | 137 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2012 | 344 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 139 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2012 | 147 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 221 | 0.090 |
Why?
|
| Glutamine | 1 | 2011 | 47 | 0.090 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2010 | 14 | 0.090 |
Why?
|
| alpha-Galactosidase | 1 | 2010 | 8 | 0.090 |
Why?
|
| Gaucher Disease | 1 | 2010 | 42 | 0.090 |
Why?
|
| Spectrometry, Mass, Secondary Ion | 4 | 1997 | 7 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 502 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1559 | 0.090 |
Why?
|
| Chemistry, Physical | 2 | 2002 | 47 | 0.090 |
Why?
|
| Technology Transfer | 1 | 2009 | 3 | 0.090 |
Why?
|
| Chemical Phenomena | 2 | 2002 | 93 | 0.080 |
Why?
|
| Models, Theoretical | 2 | 2005 | 258 | 0.080 |
Why?
|
| Endopeptidases | 1 | 2010 | 68 | 0.080 |
Why?
|
| Industry | 1 | 2009 | 61 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 96 | 0.080 |
Why?
|
| Electron Transport | 1 | 2009 | 35 | 0.080 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 376 | 0.080 |
Why?
|
| Neoplasms | 1 | 2019 | 1258 | 0.080 |
Why?
|
| Ethylmaleimide | 1 | 2008 | 8 | 0.080 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2008 | 11 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 1378 | 0.080 |
Why?
|
| Chaperonin 60 | 1 | 2008 | 19 | 0.080 |
Why?
|
| Cardiovirus Infections | 1 | 2008 | 13 | 0.080 |
Why?
|
| Encephalomyocarditis virus | 1 | 2008 | 14 | 0.080 |
Why?
|
| Universities | 1 | 2009 | 152 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 252 | 0.080 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2007 | 5 | 0.070 |
Why?
|
| Thermodynamics | 2 | 2005 | 194 | 0.070 |
Why?
|
| Acyltransferases | 2 | 1998 | 32 | 0.070 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2007 | 9 | 0.070 |
Why?
|
| Caulobacter crescentus | 1 | 2008 | 34 | 0.070 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2007 | 27 | 0.070 |
Why?
|
| Globins | 1 | 2007 | 24 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 730 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2008 | 257 | 0.070 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2007 | 90 | 0.070 |
Why?
|
| Ethanol | 1 | 2010 | 307 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2007 | 353 | 0.070 |
Why?
|
| Molecular Weight | 2 | 1997 | 189 | 0.070 |
Why?
|
| Models, Biological | 1 | 2011 | 1141 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2005 | 35 | 0.060 |
Why?
|
| Hordeum | 1 | 2005 | 3 | 0.060 |
Why?
|
| Bismuth | 1 | 2004 | 3 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2005 | 61 | 0.060 |
Why?
|
| Homeostasis | 1 | 2007 | 343 | 0.060 |
Why?
|
| Linear Energy Transfer | 1 | 2004 | 3 | 0.060 |
Why?
|
| Surface Properties | 1 | 2005 | 273 | 0.060 |
Why?
|
| Lung | 1 | 2008 | 838 | 0.050 |
Why?
|
| Retinoids | 1 | 2003 | 12 | 0.050 |
Why?
|
| Citrates | 1 | 2003 | 15 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 385 | 0.050 |
Why?
|
| Ferric Compounds | 1 | 2003 | 38 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2005 | 308 | 0.050 |
Why?
|
| Tetanus Toxoid | 1 | 2022 | 14 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2022 | 18 | 0.050 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2009 | 45 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 32 | 0.050 |
Why?
|
| Electrochemistry | 1 | 2001 | 27 | 0.050 |
Why?
|
| United States | 1 | 2015 | 7568 | 0.050 |
Why?
|
| Forecasting | 1 | 2002 | 221 | 0.050 |
Why?
|
| Heart | 1 | 2003 | 276 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2022 | 193 | 0.050 |
Why?
|
| Lipopolysaccharides | 2 | 2008 | 645 | 0.040 |
Why?
|
| Urologic Neoplasms | 1 | 2019 | 12 | 0.040 |
Why?
|
| Male | 2 | 2019 | 27765 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 50 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 2017 | 21 | 0.040 |
Why?
|
| Water | 1 | 1999 | 301 | 0.040 |
Why?
|
| Rhodobacter sphaeroides | 1 | 1997 | 7 | 0.040 |
Why?
|
| Sugar Acids | 1 | 1997 | 7 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2022 | 710 | 0.040 |
Why?
|
| Phosphotransferases | 1 | 1997 | 21 | 0.040 |
Why?
|
| Haemophilus influenzae | 1 | 1997 | 26 | 0.040 |
Why?
|
| Transferases | 1 | 1997 | 16 | 0.040 |
Why?
|
| Gramicidin | 1 | 1997 | 6 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 3589 | 0.040 |
Why?
|
| Sodium | 1 | 1997 | 61 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 1997 | 133 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1998 | 98 | 0.030 |
Why?
|
| Cations | 1 | 1997 | 63 | 0.030 |
Why?
|
| Chlamydia trachomatis | 1 | 1997 | 57 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 278 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 267 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 320 | 0.030 |
Why?
|
| Base Sequence | 3 | 2006 | 1311 | 0.030 |
Why?
|
| Trypsin | 1 | 1995 | 42 | 0.030 |
Why?
|
| Diflunisal | 1 | 1994 | 2 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 709 | 0.030 |
Why?
|
| Rabbits | 1 | 1995 | 330 | 0.030 |
Why?
|
| DNA Primers | 2 | 2006 | 291 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2013 | 89 | 0.030 |
Why?
|
| Electrophoresis, Capillary | 1 | 2013 | 8 | 0.030 |
Why?
|
| Heparitin Sulfate | 1 | 2013 | 10 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 183 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 77 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 1134 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2017 | 1459 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 942 | 0.020 |
Why?
|
| HEPES | 1 | 2009 | 1 | 0.020 |
Why?
|
| Nitrilotriacetic Acid | 1 | 2009 | 6 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2009 | 25 | 0.020 |
Why?
|
| Bicarbonates | 1 | 2009 | 14 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2100 | 0.020 |
Why?
|
| Glycine | 1 | 2009 | 45 | 0.020 |
Why?
|
| Carbonic Anhydrase II | 1 | 2008 | 4 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2009 | 124 | 0.020 |
Why?
|
| Arginine | 1 | 2009 | 113 | 0.020 |
Why?
|
| Titrimetry | 1 | 2007 | 11 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2008 | 110 | 0.020 |
Why?
|
| Substrate Specificity | 2 | 1998 | 323 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 807 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2008 | 228 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2006 | 33 | 0.020 |
Why?
|
| Phylogeny | 1 | 2007 | 334 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 294 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 584 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 708 | 0.010 |
Why?
|
| Ion Exchange | 1 | 2003 | 2 | 0.010 |
Why?
|
| Macrophages | 1 | 2008 | 1008 | 0.010 |
Why?
|
| Affinity Labels | 1 | 2001 | 9 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2002 | 528 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1540 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 3204 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 675 | 0.010 |
Why?
|
| Cosmids | 1 | 1998 | 9 | 0.010 |
Why?
|
| Carbohydrate Conformation | 1 | 1998 | 15 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1998 | 60 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1998 | 45 | 0.010 |
Why?
|
| Phosphatidic Acids | 1 | 1997 | 7 | 0.010 |
Why?
|
| Disaccharides | 1 | 1997 | 10 | 0.010 |
Why?
|
| Cell Line | 1 | 2001 | 2015 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1997 | 188 | 0.010 |
Why?
|
| Neisseria meningitidis | 1 | 1997 | 104 | 0.010 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1997 | 138 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1997 | 194 | 0.010 |
Why?
|
| Rats, Gunn | 1 | 1994 | 1 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1997 | 860 | 0.010 |
Why?
|
| Sulfates | 1 | 1994 | 14 | 0.010 |
Why?
|